Francesca Bridge, Julia Brotherton, Jim Stankovich, Paul G Sanfilippo, Olga G Skibina, Katherine Buzzard, Tomas Kalincik, Ai-Lan Nguyen, Kylie Guo, Mastura Monif, C David Wrede, Louise Rath, Lisa Taylor, Helmut Butzkueven, Vilija G Jokubaitis, Anneke Van Der Walt
BACKGROUND AND OBJECTIVES: The impact of immunomodulatory therapies on the risk of cervical pre-cancer and invasive cancer development is important for the health and safety of women with multiple sclerosis (wwMS). We investigate the risk of cervical abnormalities in wwMS treated with disease-modifying therapies (DMTs). METHODS: This is a multicenter cohort study with data collected from 1998 to 2019 in Victoria, Australia. Data linkage was performed using matching records from the MSBase Registry, the National Human Papillomavirus (HPV) Vaccination Program Register, and the Victorian Cervical Cytology Register...
February 2024: Neurology